Cases & Deals

  • Home
  • Practices
  • Jefferies and Barclays complete $231 million public offering of Common Stock by AMAG Pharmaceuticals

Share

Jefferies and Barclays complete $231 million public offering of Common Stock by AMAG Pharmaceuticals

August 2015

Client(s) Jefferies LLC and Barclays Capital Inc.

Jones Day advised Jefferies LLC and Barclays Capital Inc., as representatives of the underwriters, in connection with the $231 million public offering of Common Stock by AMAG Pharmaceuticals, Inc., a specialty pharmaceutical company with a focus on maternal health, anemia, and cancer supportive care.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.